Zhengye Biotechnology Holding Limited (ZYBT) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Zhengye Biotechnology Holding Limited (ZYBT) closed at USD 1.53 on 2026-10-14, a change of -29.8 % over the past year, with a market capitalization of USD 71.09M.

Zhengye Biotechnology Holding Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Zhengye Biotechnology Holding Limited key figures

Previous close

USD 1.53 (2026-10-14)

1-year change

-29.8 %

Market cap

USD 71.09M

Enterprise value

USD 151.15M

P/E ratio (trailing)

-6.82

P/E ratio (forward)

n/a

EPS (trailing)

-0.22

EPS (forward)

n/a

PEG ratio

n/a

Price to book

1.90

Revenue growth

-40.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.99

Employees

269

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Zhengye Biotechnology Holding Limited and compare it with other stocks.